Testing effectiveness (Phase 2)Not Yet RecruitingNCT06495515
What this trial is testing
Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study
Who this might be right for
CANCERBRAEST CANCERLate Frontline
Tianjin Medical University Cancer Institute and Hospital 36